GERON CORP — Director's Dealing 2011

May 6, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GERON CORP (GERN)
CIK: 0000886744
Period of Report: 2011-05-05

Reporting Person: Kelsey Stephen Michael (EVP, CMO, Oncology)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-05-05	Common Stock	S	14163	$4.83	Disposed	364131	Direct

Footnotes

F1: Shares sold for payment of payroll tax withholdings in connection with vesting of restricted stock award.